Revision: June 29, 2017, 2 p.m.
CHAPTER 158
HB 160 - FINAL VERSION
8Mar2017... 0681h
04/20/2017 1378s
05/11/2017 1631s
2017 SESSION
17-0117
01/09
HOUSE BILL 160
AN ACT relative to use of cannabis for therapeutic purposes.
SPONSORS: Rep. Schleien, Hills. 37; Rep. Fisher, Belk. 9; Rep. Zaricki, Hills. 6; Rep. Phinney, Straf. 24; Rep. Fromuth, Hills. 7; Rep. Josephson, Graf. 11
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
I. Adds certain conditions to the definition of "qualifying medical condition" for the purposes of the use of cannabis for therapeutic purposes law.
II. Deletes the requirement that a medical provider document how the injury affects activities of daily living.
III. Clarifies the statements signed by applicants for a registry identification card.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
8Mar2017... 0681h
04/20/2017 1378s
05/11/2017 1631s 17-0117
01/09
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Seventeen
AN ACT relative to use of cannabis for therapeutic purposes.
Be it Enacted by the Senate and House of Representatives in General Court convened:
158:1 Use of Cannabis for Therapeutic Purposes; Qualifying Conditions. RSA 126-X:1, IX(a) is repealed and reenacted to read as follows:
IX.(a)(1) "Qualifying medical condition'' means the presence of:
(A) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, Ehlers-Danlos syndrome, or one or more injuries or conditions that has resulted in one or more qualifying symptoms under subparagraph (B); and
(B) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms; or
(2) "Qualifying medical condition" also means:
(A) Moderate to severe chronic pain.
(B) Severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.
(C) Moderate or severe post-traumatic stress disorder.
158:2 Departmental Administration: Registry Identification Cards. Amend RSA 126-X:4, VI to read as follows:
VI. The department shall provide each applicant and each approved qualifying patient and designated caregiver a statement with the registry identification card explaining current federal law on the possession of cannabis [and], that possession of a state registry identification card does not protect a person from federal criminal penalties, and that by using cannabis the qualifying patient may be subject to the denial of rights and privileges by federal agencies including, but not limited to, the loss of rights related to employment such as driving a commercial vehicle, the inability to pass a security clearance, and the right to own, possess, or purchase a firearm and/or ammunition. The statement shall be updated based on any relevant changes in federal law.
158:3 Effective Date. This act shall take effect 60 days after its passage.
Approved: June 28, 2017
Effective Date: August 27, 2017